142 related articles for article (PubMed ID: 17942915)
1. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
Takami T; Kaposi-Novak P; Uchida K; Gomez-Quiroz LE; Conner EA; Factor VM; Thorgeirsson SS
Cancer Res; 2007 Oct; 67(20):9844-51. PubMed ID: 17942915
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
3. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
4. Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met.
Marx-Stoelting P; Borowiak M; Knorpp T; Birchmeier C; Buchmann A; Schwarz M
Int J Cancer; 2009 Apr; 124(8):1767-72. PubMed ID: 19123478
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis.
Gómez-Quiroz LE; Factor VM; Kaposi-Novak P; Coulouarn C; Conner EA; Thorgeirsson SS
J Biol Chem; 2008 May; 283(21):14581-9. PubMed ID: 18348981
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.
Maeda M; Takami T; Terai S; Sakaida I
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():104-11. PubMed ID: 22320927
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis.
Burr AW; Hillan KJ; McLaughlin KE; Ferrier R; Chapman C; Mathew J; Burt AD
Hepatology; 1996 Nov; 24(5):1282-7. PubMed ID: 8903411
[TBL] [Abstract][Full Text] [Related]
9. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
10. S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis.
Sundaresan S; Subramanian P
Pol J Pharmacol; 2003; 55(1):37-42. PubMed ID: 12856824
[TBL] [Abstract][Full Text] [Related]
11. Loss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.
Marquardt JU; Seo D; Gómez-Quiroz LE; Uchida K; Gillen MC; Kitade M; Kaposi-Novak P; Conner EA; Factor VM; Thorgeirsson SS
Biochim Biophys Acta; 2012 Jun; 1822(6):942-51. PubMed ID: 22386877
[TBL] [Abstract][Full Text] [Related]
12. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice.
Bell A; Chen Q; DeFrances MC; Michalopoulos GK; Zarnegar R
Oncogene; 1999 Jan; 18(4):887-95. PubMed ID: 10023664
[TBL] [Abstract][Full Text] [Related]
13. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
[TBL] [Abstract][Full Text] [Related]
14. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis.
Sánchez-Pérez Y; Carrasco-Legleu C; García-Cuellar C; Pérez-Carreón J; Hernández-García S; Salcido-Neyoy M; Alemán-Lazarini L; Villa-Treviño S
Cancer Lett; 2005 Jan; 217(1):25-32. PubMed ID: 15596293
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor promotes lung carcinogenesis in transgenic mice treated with diethylnitrosamine.
Kojima A; Horiguchi N; Kakizaki S; Takayama H; Mori M
Anticancer Res; 2013 Mar; 33(3):895-901. PubMed ID: 23482759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
